Stay updated with breaking news from Exosome Engineering Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing biologics and cell therapies intended to enhance the function of Regulatory T Cells , today announced its financial...
Supported by promising data generated during the option period, Coya has entered into an exclusive license for a next-generation EET platform to enable engineering of exosomes with potential to target epitope driven neurodegenerative, autoimmune and oncologic diseases;Exosomes are a nanometer-sized type of extracell...